Literature DB >> 32335512

Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs.

Giovanni Filocamo1, Francesca Minoia2, Simone Carbogno2, Stefania Costi3, Micol Romano3, Rolando Cimaz.   

Abstract

Entities:  

Year:  2020        PMID： 32335512     DOI： 10.3899/jrheum.200483

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  12 in total

1.  Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic.

Authors:  Fatih Haslak; Mehmet Yildiz; Amra Adrovic; Sezgin Sahin; Oya Koker; Ayten Aliyeva; Kenan Barut; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2020-07-13       Impact factor: 2.631

2.  Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.

Authors:  Xabier Michelena; Helena Borrell; Mireia López-Corbeto; María López-Lasanta; Estefanía Moreno; María Pascual-Pastor; Alba Erra; Mayte Serrat; Esther Espartal; Susana Antón; Gustavo Adolfo Añez; Raquel Caparrós-Ruiz; Andrea Pluma; Ernesto Trallero-Araguás; Mireia Barceló-Bru; Miriam Almirall; Juan José De Agustín; Jordi Lladós; Antonio Julià; Sara Marsal
Journal:  Semin Arthritis Rheum       Date:  2020-05-16       Impact factor: 5.532

Review 3.  Implications of COVID-19 in pediatric rheumatology.

Authors:  Ezgi Deniz Batu; Seza Özen
Journal:  Rheumatol Int       Date:  2020-06-04       Impact factor: 2.631

4.  COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment.

Authors:  Tatjana Welzel; Samuel Dembi Samba; Reinhild Klein; Johannes N van den Anker; Jasmin B Kuemmerle-Deschner
Journal:  J Clin Med       Date:  2021-02-05       Impact factor: 4.241

5.  Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases.

Authors:  D Sofia Villacis-Nunez; Christina A Rostad; Kelly Rouster-Stevens; Arezou Khosroshahi; Shanmuganathan Chandrakasan; Sampath Prahalad
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-21       Impact factor: 3.054

6.  COVID-19 in a child with severe aplastic anemia.

Authors:  Yunus Murat Akcabelen; Ayca Koca Yozgat; Asli Nur Parlakay; Nese Yarali
Journal:  Pediatr Blood Cancer       Date:  2020-06-15       Impact factor: 3.167

7.  Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19.

Authors:  Oya Koker; Fatma Gul Demirkan; Gulsah Kayaalp; Figen Cakmak; Ayse Tanatar; Serife Gul Karadag; Hafize Emine Sonmez; Rukiye Omeroglu; Nuray Aktay Ayaz
Journal:  Rheumatol Int       Date:  2020-08-02       Impact factor: 2.631

Review 8.  Autoimmunity as the comet tail of COVID-19 pandemic.

Authors:  Rossella Talotta; Erle Robertson
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

9.  American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1.

Authors:  Dawn M Wahezi; Mindy S Lo; Tamar B Rubinstein; Sarah Ringold; Stacy P Ardoin; Kevin J Downes; Karla B Jones; Ronald M Laxer; Rebecca Pellet Madan; Amy S Mudano; Amy S Turner; David R Karp; Jay J Mehta
Journal:  Arthritis Rheumatol       Date:  2020-09-28       Impact factor: 15.483

10.  COVID-19 and immune-mediated inflammatory diseases: Why don't our patients get worse?

Authors:  Víctor M Martínez-Taboada; Marcos López-Hoyos; Javier Crespo; José L Hernández
Journal:  Autoimmun Rev       Date:  2020-10-27       Impact factor: 9.754
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.